3 Areas of Opportunity for Private Equity Investment in Life Sciences | McDermott Skip to main content

3 Areas of Opportunity for Private Equity Investment in Life Sciences

3 Areas of Opportunity for Private Equity Investment in Life Sciences

Overview




The life sciences investment space has been largely immune to the negative impacts of the COVID-19 pandemic. Growth in the pharmaceutical, biotechnology and medical device industries has led to increased interest from private equity investors, many of which are new to the life sciences market.

In this video we address:

  • Three areas ripe for private equity investment in the life sciences arena
  • Sector-specific due diligence concerns investors should address
  • Opportunities for ROI when investing in life sciences and life sciences adjacent companies

Dig Deeper

Boston, MA / In-person / November 13, 2025

Life Sciences Investment Forum 2025

Chicago, IL & Virtual / In-person / October 28, 2025

Healthcare Litigation, Compliance, and Investigations Forum 2025

New York, NY / In-person / October 16, 2025

HPE NYC 2025

Atlanta, Georgia / Speaking Engagements / October 8, 2025

Advanced Health Law

Paris, France / Speaking Engagements / October 7-8, 2025

HTID | Healthtech Innovation Days 2025

Verona, WI / Speaking Engagements / September 24-25, 2025

Open@Epic Conference 2025

Get In Touch